Skip to main content
Log in

Aneurysmal change of the ductus arteriosus after prostaglandin E1 administration for pulmonary atresia: Demonstration with magnetic resonance imaging

  • Case Reports
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Summary

We report a case of pulmonary atresia in which the ductus arteriosus underwent aneurysmal dilatation after infusion of prostaglandin E1 incorporated in lipid microspheres. To our knowledge this is the first case in which this rare morphological change has been demonstrated with the noninvasive method of magnetic resonance imaging.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chung KJ, Simpson IA (1990) Magnetic resonance imaging of congenital heart disease: right heart lesions. In: Crupi G, Parenzan L, Anderson RH (eds)Perspectives in pediatric cardiology, vol. 2,Pediatric cardiac surgery, part 3, Futura, New York, pp 66–68

    Google Scholar 

  2. Cole RB, Abman S, Aziz KU, Bharati S, Lev M (1981) Prolonged prostaglandin E1 infusion: histological effects on the patent ductus arteriosus.Pediatricus 67:816–819

    Google Scholar 

  3. Freed MD, Heymann MA, Lewis AB, Roehl SL, Kensey RC (1981) Prostaglandin E1 in infants with ductus arteriosus-dependent congenital heart disease.Circulation 64:899–905

    Google Scholar 

  4. Lewis AB, Freed MD, Heymann MA, Roehl SL, Kensey RC (1981) Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease.Circulation 64:893–898

    Google Scholar 

  5. Momma K, Takao A (1987) Lipo prostaglandin E1 (Lipo PGE1) in the treatment of infants with ductus-arteriosus-dependent pulmonary blood flow.Circulation 76 (suppl IV): 25

    Google Scholar 

  6. Pitlick P, French JW, Maze A, Kimble KJ, Ariagno RL, Reitz BA (1980) Long-term low-dose prostaglandin E1 administration.J Pediatr 96:318–320

    Google Scholar 

  7. Silver MM, Freedom RM, Silver MD, Olley PM (1981) The morphology of the human newborn ductus arteriosus: a reappraisal of its structure and closure with special reference to prostaglandin E1 therapy.Hum Pathol 12:1123–1136

    Google Scholar 

  8. Teixeira OHP, Carpenter B, MacMurray SB, Vlad P (1984) Long-term prostaglandin E1 therapy in congenital heart defects.JACC 3:838–843

    Google Scholar 

  9. Ueda K, Saito A, Nakano H, et al. (1980) Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease.J Pediatr 97:834–836

    Google Scholar 

  10. Yokota M, Muraoka R, Aoshima M, et al. (1985) Modified Blalock-Taussig shunt following long-term administration of prostaglandin E1 for ductus-dependent neonates with cyanotic congenital heart disease.J Thorac Cardiovasc Surg 90:399–403

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tsubata, S., Hashimoto, I., Ichida, F. et al. Aneurysmal change of the ductus arteriosus after prostaglandin E1 administration for pulmonary atresia: Demonstration with magnetic resonance imaging. Pediatr Cardiol 15, 30–32 (1994). https://doi.org/10.1007/BF00797003

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00797003

Key words

Navigation